Vanguard Personalized Indexing Management, LLC Lyell Immunopharma, Inc. Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.61 Billion
- Q1 2025
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 32,887 shares of LYEL stock, worth $13,483. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32,887
Previous 22,377
46.97%
Holding current value
$13,483
Previous $14,000
21.43%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding LYEL
# of Institutions
117Shares Held
175MCall Options Held
2.9KPut Options Held
6K-
Mwg Management Ltd. Washington, DC20.2MShares$8.27 Million18.54% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA16MShares$6.56 Million9.84% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$6.19 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$6.19 Million9.84% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$5.53 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $102M
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...